Pine Labs Shares In Focus As Emkay Initiates Coverage With A 'Reduce' Call - Check Target Price And Key Risks
Emkay listed "premium valuations amid rising competition" as key risks for investors looking to invest in Pine Labs.
What's Your Reaction?